Citicoline May Prevent Cognitive Decline in Patients with Cerebrovascular Disease.

Introduction: Neuroprotective drugs such as citicoline could improve cognitive performance and quality of life. We studied the effect of citicoline treatment and its association with Vascular Risk Factors (VRF) and APOE on cognition in patients with Subjective Cognitive Complaints (SCC) and Mild Cognitive Impairment (MCI).

Methods: This is an observational and prospective study with citicoline during 12 months follow-up.